Winton Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $471K | Buy |
|
|||||
|
2023
Q1 | $663K | Buy |
|
|||||
|
2022
Q4 | $578K | Sell |
|
|||||
|
2022
Q3 | $820K | Buy |
|
|||||
|
2022
Q2 | $958K | Buy |
|
|||||
|
2022
Q1 | $808K | Buy |
|
|||||
|
2021
Q4 | $516K | Sell |
|
|||||
|
2021
Q3 | $1.14M | Sell |
|
|||||
|
2021
Q2 | $1.05M | Sell |
|
|||||
|
2021
Q1 | $1.12M | Buy |
|
|||||
|
2020
Q4 | $793K | Sell |
|
|||||
|
2020
Q3 | $1.25M | Sell |
|
|||||
|
2020
Q2 | $5.65M | Sell |
|
|||||
|
2020
Q1 | $6.5M | Sell |
|
|||||
|
2019
Q4 | $9.27M | Buy |
|
|||||
|
2019
Q3 | $361K | Buy |
|
|||||
|
2019
Q2 | $314K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $9.55M | Buy |
|